Figure 1.
Footnotes: i: 40–49, 50–59, 60–69, 70+. j: Current Smoker, Previous Smoker, Never Smoker. t: Time. UD: Undiagnosed; TP: True Positive; TN: True Negative; FP: False Positive; FN: False Negative. The model ran separately for men and women.
Table 1.
Key input parameters in the model.
Table 2.
Outcomes of hypothetical interventions.
Figure 2.
The projected increase in the prevalence of COPD in Canada in men (A) and women (B) across disease severities.
Figure 3.
The projected changes in the costs related to COPD in Canada in men (A) and women (B) at various discount rates.
Figure 4.
The projected changes in quality adjusted life years lost related to COPD in Canada in men (A) and women (B).
Figure 5.
The results of one-way sensitivity analyses on the total cost related to COPD in Canada over the next 25 years.
Figure 6.
The estimated monetary benefit of each hypothetical intervention assuming different scenarios for effectiveness of these interventions in reducing smoking rates (intervention I), progression of disease (intervention II), and exacerbation rates (intervention II).